111 Price to Sales Ratio 2018-2023 | YI

Historical PS ratio values for 111 (YI) over the last 10 years. The current P/S ratio for 111 as of May 03, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
111 P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-05-03 1.15 0.05
2023-09-30 2.60 $24.86 0.10
2023-06-30 2.46 $24.57 0.10
2023-03-31 2.65 $24.31 0.11
2022-12-31 3.02 $23.53 0.13
2022-09-30 2.68 $23.58 0.11
2022-06-30 2.06 $24.19 0.09
2022-03-31 2.66 $24.39 0.11
2021-12-31 3.50 $23.52 0.15
2021-09-30 6.17 $22.24 0.28
2021-06-30 9.09 $17.47 0.52
2021-03-31 13.80 $13.02 1.06
2020-12-31 6.95 $9.85 0.71
2019-06-30 5.56 $8.52 0.65
2019-03-31 6.49 $9.81 0.66
2018-09-30 13.52 $11.33 1.19
2020-09-30 6.20 $12.07 0.51
2020-06-30 6.35 $9.74 0.65
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.096B $2.105B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $36.275B 19.92
Inspire Medical Systems (INSP) United States $7.566B 0.00
Axonics (AXNX) United States $3.432B 0.00
10x Genomics (TXG) United States $3.275B 0.00
IRhythm Technologies (IRTC) United States $3.196B 0.00
Azenta (AZTA) United States $2.979B 242.82
Olink Holding AB (publ) (OLK) Sweden $2.861B 0.00
Enovis (ENOV) United States $2.812B 20.84
Hims & Hers Health (HIMS) United States $2.412B 0.00
Privia Health (PRVA) United States $2.224B 98.63
Schrodinger (SDGR) United States $1.712B 0.00
Omnicell (OMCL) United States $1.384B 47.83
Phreesia (PHR) United States $1.259B 0.00
Definitive Healthcare (DH) United States $0.828B 0.00
Standard BioTools (LAB) United States $0.728B 0.00
Fulgent Genetics (FLGT) United States $0.643B 0.00
Talkspace (TALK) United States $0.538B 0.00
Health Catalyst (HCAT) United States $0.383B 0.00
Pulmonx (LUNG) United States $0.378B 0.00
Clover Health Investments (CLOV) United States $0.344B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.326B 0.00
P3 Health Partners (PIII) United States $0.202B 0.00
Butterfly Network (BFLY) United States $0.196B 0.00
American Well (AMWL) United States $0.165B 0.00
Outset Medical (OM) United States $0.162B 0.00
Augmedix (AUGX) United States $0.133B 0.00
MSP Recovery (LIFW) United States $0.125B 0.00
TruBridge (TBRG) United States $0.125B 5.33
Mobile-health Network Solutions (MNDR) Singapore $0.108B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.068B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Zepp Health (ZEPP) China $0.053B 0.00
Movano (MOVE) United States $0.046B 0.00
EUDA Health Holdings (EUDA) Singapore $0.044B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Akili (AKLI) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.024B 0.00
Cue Health (HLTH) United States $0.022B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.015B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Syra Health (SYRA) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00